Impact of order of application of moisturizers on percutaneous absorption kinetics: Evaluation of sequential application of moisturizer lotions and azelaic acid gel 15% using a human skin model

Cutis

Volumn 83, Issue 3, 2009, Pages 119-124

  Del Rosso, James Q ^a   Lehman, Paul A ^b   Raney, Sam G ^b  

^a VALLEY HOSPITAL MEDICAL CENTER   (United States)

^b Cetero Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZELAIC ACID; CETAPHIL; DERMATOLOGICAL AGENT; DICARBOXYLIC ACID; DODECYL SULFATE SODIUM; EMOLLIENT AGENT; PROPANEDIOL DERIVATIVE;

ARTICLE; DRUG COMBINATION; DRUG EFFECT; HUMAN; IN VITRO STUDY; KINETICS; ROSACEA; SKIN ABSORPTION; THERMOREGULATION; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; DERMATOLOGIC AGENTS; DICARBOXYLIC ACIDS; DRUG COMBINATIONS; EMOLLIENTS; HUMANS; KINETICS; PROPYLENE GLYCOLS; ROSACEA; SKIN ABSORPTION; SODIUM DODECYL SULFATE; WATER LOSS, INSENSIBLE;

EID: 66149102876     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Del Rosso JQ. Medical treatment of rosacea with emphasis on topical therapies. Expert Opin Pharmacother. 2004;5:5-13.
2. Bikowski JB. The pharmacologic therapy of rosacea: a paradigm shift in progress. Cutis. 2005;75(suppl 3):27-32.
3. Bikowski JB, Goldman MP. Rosacea: where are we now? J Drugs Dermatol. 2004;3:251-261.
4. Del Rosso JQ. Adjunctive skin care in the management of rosacea: cleansers, moisturizers, and photoprotectants. Cutis. 2005;75(suppl 3):17-21.
5. Del Rosso JQ. The role of skin care and maintaining proper barrier function in the management of rosacea. Cosmet Dermatol. 2007;20:485-490.
6. Draelos ZD. Concepts in skin care maintenance. Cutis. 2005;76(suppl 6):19-25.
7. Bikowski J. The use of therapeutic moisturizers in various dermatologic disorders. Cutis. 2001;68(suppl 5):3-11.
8. Lebwohl M, Herrmann LG. Impaired skin barrier function in dermatologic disease and repair with moisturization. Cutis. 2005;76(suppl 6):7-12.
9. Ghali FE. Improved clinical outcomes with moisturization in dermatologic disease. Cutis. 2005;76(suppl 6):13-18.
10. Dirschka T, Tronnier H, Folster-Holst R. Epithelial barrier function and atopic diathesis in rosacea and perioral dermatitis. Br J Dermatol. 2004;150:1136-1141.
11. Franz TJ. Percutaneous absorption on the relevance of in vitro data. J Invest Dermatol. 1975;64:190-195.
12. Franz TJ. The finite dose technique as a valid in vitro model for the study of percutaneous absorption in man. In: Simon GA, Paster Z, Klingberg MA, et al, eds. Skin: Drug Application and Evaluation of Environmental Hazards, Current Problems in Dermatology. Vol 7. Basel, Switzerland: S Karger; 1978:58-68.
13. Franz TJ, Lehman PA. The use of water permeability as a means of validation for skin integrity in in vitro percutaneous absorption studies [abstract]. J Invest Dermatol. 1990;94:525.
14. Finacea [package insert]. Pine Brook, NJ: Intendis, Inc; 2005.